Exploratory Study on a Multi-nutrient Supplement and Exercise Program for Improving Health Markers Associated to Longevity in Pre-frail Adults

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorNational University of Singapore

About this trial

Frailty is associated with biological changes in the gut microbiome and immune system, along with marked declines in physical and cognitive function, leading to an overall reduction in quality of life. Prefrailty represents an early stage where interventions may prevent or reverse these declines. This study aims to evaluate whether a 12-week combined Synbiotic enriched oral nutritional supplement and supervised exercise program can improve muscle strength and mass, gut microbiome composition, immune function, and cognitive performance in prefrail adults aged 50-80 years.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Singapore residents of all ethnic groups

Adults aged 50-80 years (both male and female)

Body mass index (BMI) ≥18 kg/m²

Classified as Prefrailty according to Fried frailty criteria

Disqualifiers

Current use of supplements containing: Bifidobacterium longum 536 (BB536) like Kordel's BB536 bifidus; Bifidobacterium longum such as GniiB immunity; GOS (Galacto-oligosaccharides); FOS (Fructo-oligosaccharides); Inulin or any commercial healthy-aging powdered milk products

BMI >30 kg/m2 3 Being on special diets including but not limited to ketogenic diets or diets prescribed by a healthcare professional

Trial design

Design model

Single group

Treatments tested in this trial

  • Supervised exercise program

    Behavioral

    A supervised exercise intervention consisting of resistance and endurance training, delivered two times per week, with each session lasting 60 minutes, conducted by an exercise physiologist in the gym's clinic in Singapore.

  • a balanced micronutrient blend

    Dietary supplement

    A balanced micronutrient blend containing soral nutritional supplement in powder form containing a synbiotic blend of prebiotics and probiotic, a protein blend and a micronutrient blend provided by Danone Global R\&I Center. The participant will be required to take two servings of the study product daily for 12 weeks.

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Intervention ArmExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Change in muscle mass measured via B- mode ultrasound

Change from baseline to Week 12 in muscle mass assessed by muscle thickness measured using B-mode ultrasound. Muscle thickness was measured in centimeters (cm) at a predefined anatomical site

Time frame
Baseline and 12 weeks
2

Change on Fecal Bifidobacterium level measured via stool microbiome analysis

Change from baseline at 6 and 12 weeks in stool Bifidobacterium abundance, measured by quantitative PCR (qPCR), and in microbiome diversity, measured by 16S rRNA gene sequencing and shotgun metagenomic sequencing.

Time frame
Baseline, 6 weeks and 12 weeks

Secondary outcomes

1

Change in cognitive performance National Institutes of Health Toolbox Cognition Battery - Fluid composite

Change from baseline to 12 weeks in cognitive performance assessed by the National Institutes of Health Toolbox Cognition Battery - Fluid composite. \[scores of 0 to 100 in raw or age-corrected scaled score\]

Time frame
Baseline and 12 weeks
2

Change in the immune function (CD4+: CD8+ ratio)

Change from baseline at 6 weeks and 12 weeks in CD4+: CD8+ in T-cell ratio

Time frame
Baseline, 6 weeks and 12 weeks
3

Change in cardiorespiratory fitness (Peak VO₂)

Change from baseline to 12 weeks in maximal oxygen uptake (VO₂peak) assessed using standardized cardiopulmonary exercise testing (mL/kg/min)

Time frame
Baseline and 12 weeks
4

Change in Muscle Strength assessed using 1RM strength test

Change from baseline to 12 weeks in 1RM strength (Smith machine bench press) (Kg)

Time frame
Baseline and 12 weeks

Other outcomes

1

Study participation and retention rates

Participation rate defined as the percentage of eligible participants enrolled, and dropout rate defined as the percentage of participants who discontinue the study and reasons for dropout

Time frame
12 weeks
2

Adherence to supplement intervention

Supplement adherence, measured as the proportion (%) and total number of prescribed doses taken, as verified by returned empty sachet counts at each visit.

Time frame
12 weeks
3

Adherence to exercise intervention

Adherence to the exercise intervention, assessed as the number and percentage of scheduled exercise sessions attended, as recorded by study staff.

Time frame
12 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

National University of Singapore

Lead sponsor

Danone Global Research & Innovation Center

Collaborator